Ambrisentan Therapy for Pulmonary Arterial Hypertension
Top Cited Papers
- 7 July 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 46 (3), 529-535
- https://doi.org/10.1016/j.jacc.2005.04.050
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- The endothelin system in pulmonary arterial hypertensionCardiovascular Research, 2004
- Bosentan Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine, 2002
- Primary Pulmonary HypertensionChest, 1998
- Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.Circulation, 1994
- Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension.Circulation Research, 1993
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionNew England Journal of Medicine, 1993
- Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?Annals of Internal Medicine, 1991
- A critical review of visual analogue scales in the measurement of clinical phenomenaResearch in Nursing & Health, 1990
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988